Immunological characterization of human membrane-bound arylamidases from small intestine, lung, kidney, liver, placenta and renal cell carcinoma.
Anti-placental and anti-kidney membrane-bound arylamidase antibodies were prepared in rabbits. Both antibodies showed similar titration curves against both the original antigens, and the membrane-bound arylamidases partially purified from small intestine, lung, liver and renal cell carcinoma. Double immunidiffusion tests showed that six membrane-bound arylamidases were immunochemically indistinguishable.
D000230:Adenocarcinoma / Q000201:enzymology*; D000626:Aminopeptidases / Q000032:analysis* / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology; D005779:Immunodiffusion / Q000379:methods; D007421:Intestine, Small / Q000201:enzymology; D007668:Kidney / Q000201:enzymology; D007680:Kidney Neoplasms / Q000201:enzymology*; D008099:Liver / Q000201:enzymology; D008168:Lung / Q000201:enzymology; D008566:Membranes / Q000201:enzymology*; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy
D007106:Immune Sera; D000626:Aminopeptidases